Moving toward an understanding of the metastatic process in hepatocellular carcinoma

doi:10.3748/wjg.v7.i6.777

Review

. 2001 Dec;7(6):777-8.

doi: 10.3748/wjg.v7.i6.777.

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

W M Korn¹

Affiliations

PMID: 11854899
PMCID: PMC4695592
DOI: 10.3748/wjg.v7.i6.777

Review

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

W M Korn. World J Gastroenterol. 2001 Dec.

. 2001 Dec;7(6):777-8.

doi: 10.3748/wjg.v7.i6.777.

Author

W M Korn¹

Affiliation

¹ Division of Gastroenterology and Comprehensive Cancer Center, University of California, San Francisco 94143-0128, USA. mkorn@cc.ucsf.edu

PMID: 11854899
PMCID: PMC4695592
DOI: 10.3748/wjg.v7.i6.777

No abstract available

PubMed Disclaimer

Comment on

Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97.
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue Q, Chen J, Gao DM, Bao WH. Li Y, et al. World J Gastroenterol. 2001 Oct;7(5):630-6. doi: 10.3748/wjg.v7.i5.630. World J Gastroenterol. 2001. PMID: 11819844 Free PMC article.

Cited by

Experimental study of anti-tumor effects of polysaccharides from Angelica sinensis.
Shang P, Qian AR, Yang TH, Jia M, Mei QB, Cho CH, Zhao WM, Chen ZN. Shang P, et al. World J Gastroenterol. 2003 Sep;9(9):1963-7. doi: 10.3748/wjg.v9.i9.1963. World J Gastroenterol. 2003. PMID: 12970885 Free PMC article.
Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY, Lu WQ, Huang GW, Wang W. Yang LY, et al. BMC Cancer. 2006 May 2;6:110. doi: 10.1186/1471-2407-6-110. BMC Cancer. 2006. PMID: 16650286 Free PMC article.
Can heme oxygenase-1 be a prognostic factor in patients with hepatocellular carcinoma?
Park CS, Eom DW, Ahn Y, Jang HJ, Hwang S, Lee SG. Park CS, et al. Medicine (Baltimore). 2019 Jun;98(26):e16084. doi: 10.1097/MD.0000000000016084. Medicine (Baltimore). 2019. PMID: 31261522 Free PMC article.
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.
Scaggiante B, Kazemi M, Pozzato G, Dapas B, Farra R, Grassi M, Zanconati F, Grassi G. Scaggiante B, et al. World J Gastroenterol. 2014 Feb 7;20(5):1268-88. doi: 10.3748/wjg.v20.i5.1268. World J Gastroenterol. 2014. PMID: 24574801 Free PMC article. Review.
Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma.
Lin YC, Wu MY, Li DR, Wu XY, Zheng RM. Lin YC, et al. World J Gastroenterol. 2004 Nov 15;10(22):3235-9. doi: 10.3748/wjg.v10.i22.3235. World J Gastroenterol. 2004. PMID: 15484291 Free PMC article.

See all "Cited by" articles

References

1. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer. 2001;91:2378–2385. - PubMed
1. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403. - PubMed
1. Ouchi K, Sugawara T, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H, Nakagawa K. Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection. J Surg Oncol. 2000;75:241–245. - PubMed
1. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed
1. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome. Cancer. 2000;88:538–543. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer. 2001;91:2378–2385. - PubMed

[2] Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N. Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: metaanalysis of three randomized controlled trials. Cancer. 2001;91:2378–2385. - PubMed

[3] Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403. - PubMed

[4] Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403. - PubMed

[5] Ouchi K, Sugawara T, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H, Nakagawa K. Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection. J Surg Oncol. 2000;75:241–245. - PubMed

[6] Ouchi K, Sugawara T, Fujiya T, Kamiyama Y, Kakugawa Y, Mikuni J, Yamanami H, Nakagawa K. Prediction of recurrence and extratumor spread of hepatocellular carcinoma following resection. J Surg Oncol. 2000;75:241–245. - PubMed

[7] Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed

[8] Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed

[9] Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome. Cancer. 2000;88:538–543. - PubMed

[10] Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome. Cancer. 2000;88:538–543. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

Affiliation

Moving toward an understanding of the metastatic process in hepatocellular carcinoma

Author

Affiliation

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical